Terms: = Leukemia AND TNFRSF14, Q92956, 8764, ENSG00000157873, TR2, ATAR, LIGHTR, HVEM, HVEA AND Prognosis
6 results:
1. m6A-Regulator Expression Signatures Identify a Subset of Follicular Lymphoma Harboring an Exhausted Tumor Microenvironment.
Zhang T; Liu H; Gao F; Gong W; Cui Y; He J; Li L; Qiu L; Qian Z; Zhou S; Meng B; Ren X; Zhang H; Wang X
Front Immunol; 2022; 13():922471. PubMed ID: 35734168
[TBL] [Abstract] [Full Text] [Related]
2. [Expression and Significance of BTLA and Its Ligand hvem in Patients with Chronic Myelomonocytic leukemia].
Li C; Geng SX; Li MM; Su F; Chen XM; Deng CX; Huang X; Lai PL; Weng JY; DU X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):56-62. PubMed ID: 32027253
[TBL] [Abstract] [Full Text] [Related]
3. Expression of Immune Checkpoint Receptors on T-Cells and Their Ligands on leukemia Blasts in Childhood Acute leukemia.
Kang SH; Hwang HJ; Yoo JW; Kim H; Choi ES; Hwang SH; Cho YU; Jang S; Park CJ; Im HJ; Seo JJ; Kim N; Koh KN
Anticancer Res; 2019 Oct; 39(10):5531-5539. PubMed ID: 31570447
[TBL] [Abstract] [Full Text] [Related]
4. Chemotherapy for initial induction failures in childhood acute lymphoblastic leukemia: a Children's Oncology Group Study (POG 8764).
Joyce MJ; Pollock BH; Devidas M; Buchanan GR; Camitta B
J Pediatr Hematol Oncol; 2013 Jan; 35(1):32-5. PubMed ID: 23211688
[TBL] [Abstract] [Full Text] [Related]
5. Expression and prognostic value of FAS receptor/FAS ligand and TrailR1/TrailR2 in acute myeloid leukemia.
Pordzik S; Petrovici K; Schmid C; Kroell T; Schweiger C; Köhne CH; Schmetzer H
Hematology; 2011 Nov; 16(6):341-50. PubMed ID: 22183068
[TBL] [Abstract] [Full Text] [Related]
6. Stimulation of non-Hodgkin's lymphoma via hvem: an alternate and safe way to increase Fas-induced apoptosis and improve tumor immunogenicity.
Costello RT; Mallet F; Barbarat B; Schiano De Colella JM; Sainty D; Sweet RW; Truneh A; Olive D
Leukemia; 2003 Dec; 17(12):2500-7. PubMed ID: 14562115
[TBL] [Abstract] [Full Text] [Related]
